Xponance Inc. Has $903,000 Stock Position in Option Care Health, Inc. (NASDAQ:OPCH)

Xponance Inc. lowered its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 2.0% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 26,818 shares of the company’s stock after selling 540 shares during the quarter. Xponance Inc.’s holdings in Option Care Health were worth $903,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Securian Asset Management Inc. grew its holdings in shares of Option Care Health by 3.4% during the 3rd quarter. Securian Asset Management Inc. now owns 15,235 shares of the company’s stock worth $493,000 after purchasing an additional 503 shares in the last quarter. Sheets Smith Wealth Management grew its holdings in shares of Option Care Health by 1.6% during the 3rd quarter. Sheets Smith Wealth Management now owns 32,542 shares of the company’s stock worth $1,053,000 after purchasing an additional 510 shares in the last quarter. Alliance Wealth Advisors LLC UT lifted its position in shares of Option Care Health by 7.7% during the 3rd quarter. Alliance Wealth Advisors LLC UT now owns 11,234 shares of the company’s stock worth $363,000 after buying an additional 802 shares during the period. State of Alaska Department of Revenue lifted its position in shares of Option Care Health by 4.3% during the 3rd quarter. State of Alaska Department of Revenue now owns 21,376 shares of the company’s stock worth $691,000 after buying an additional 880 shares during the period. Finally, Tower Research Capital LLC TRC lifted its position in shares of Option Care Health by 11.0% during the 3rd quarter. Tower Research Capital LLC TRC now owns 9,190 shares of the company’s stock worth $297,000 after buying an additional 913 shares during the period. Institutional investors and hedge funds own 98.05% of the company’s stock.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. purchased 35,000 shares of Option Care Health stock in a transaction that occurred on Monday, February 26th. The stock was purchased at an average cost of $31.55 per share, with a total value of $1,104,250.00. Following the completion of the transaction, the director now owns 269,528 shares of the company’s stock, valued at approximately $8,503,608.40. The purchase was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Insiders own 0.64% of the company’s stock.

Option Care Health Stock Down 2.1 %

NASDAQ OPCH opened at $29.29 on Friday. The stock has a fifty day moving average of $32.04 and a 200-day moving average of $31.50. The stock has a market capitalization of $5.09 billion, a P/E ratio of 19.27, a price-to-earnings-growth ratio of 1.65 and a beta of 1.22. Option Care Health, Inc. has a 52 week low of $24.23 and a 52 week high of $35.74. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.33 and a current ratio of 1.77.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Tuesday, April 23rd. The company reported $0.26 EPS for the quarter, beating the consensus estimate of $0.22 by $0.04. The company had revenue of $1.15 billion during the quarter, compared to analysts’ expectations of $1.10 billion. Option Care Health had a return on equity of 18.92% and a net margin of 6.15%. The business’s revenue for the quarter was up 12.8% on a year-over-year basis. During the same period last year, the firm earned $0.21 EPS. On average, equities research analysts forecast that Option Care Health, Inc. will post 1.17 EPS for the current year.

Wall Street Analyst Weigh In

Several research firms recently commented on OPCH. Jefferies Financial Group raised their target price on Option Care Health from $36.00 to $38.00 and gave the stock a “buy” rating in a research report on Monday, March 4th. Barrington Research restated an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research report on Wednesday.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.